Results

Total Results: 3,378 records

Showing results for "description".

701. How to Report Results of the CAHPS Clinician & Group Survey (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cg/cgkit/HowtoReportResultsofCGCAHPS080610FINAL.pdf
     August 01, 2010 - Participants in the first round struggled slightly with the length of the description of this measure … Participants did not discuss any difficulties with the description of this measure. … In rounds one and two, participants found the description to be lengthy and stated that they had to … re-read the second sentence to better understand the description. … second sentence to better understand the description.

702. Looking to the Future of EvidenceNOW and Primary Care Quality Improvement | Agency for Healthcare Research and Quality
     www.ahrq.gov/evidencenow/projects/heart-health/research-results/videos/looking-to-future.html
     September 01, 2021 - Looking to the Future of EvidenceNOW and Primary Care Quality Improvement [3 minutes, 55 seconds] Audio description

703. CHIPRA 225: Section 2, Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-225-section-2-tech-specs.pdf
     June 17, 2019 - Table 7-A: Codes to Identify Ambulatory or Preventive Care Visits Description CPT HCPCS ICD-9-CM … Measure 7: Anticipatory Guidance for Prevention of Stroke in Children with Sickle Cell Disease Description

704. CHIPRA 226: Section 2, Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-226-section-2-tech-specs.pdf
     June 19, 2019 - Table 8-A: Codes to Identify Ambulatory or Preventive Care Visits Description CPT HCPCS ICD-9-CM … Anticipatory Guidance Regarding School Attendance/Performance for Children with Sickle Cell Disease Description

705. CHIPRA 224: Section 2, Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-224-section-2-tech-specs.pdf
     May 10, 2019 - Table 6-A: Codes to Identify Ambulatory or Preventive Care Visits Description CPT HCPCS ICD-9-CM … Prevention and/or Management of Fever and Severe Infection for Children with Sickle Cell Disease Description

706. CHIPRA 223: Section 2 Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-223-section-2-tech-specs.pdf
     April 29, 2019 - Table 5-A: Codes to Identify Ambulatory or Preventive Care Visits Description CPT HCPCS ICD-9-CM … Measure 5: Anticipatory Guidance for Pain Management for Children with Sickle Cell Disease Description

707. CLABSI Learning From Defects Tool (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/clabsi-learning-from-defects_revised.docx
     April 01, 2022 - In a brief description, document what happened from at least two different staff members. … In a brief description, identify actions that prevented the CLABSI from getting worse.

708. Figure 1. Meta-analysis of the effect of screening and feedback on the proportion of patients with persistent depression | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/resources/depression/depsumfig1.html
     April 01, 2013 - reduction in persistent depression with screening as compared to no screening Select for Text Description

709. Facilities/Basement | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/shuttered/toolkitchecklist/facbase.html
     July 01, 2018 - of flooding:         General condition:         Description

710. Making Healthcare Safer Practices: 16. Venous Thromboembolism (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
     March 01, 2020 - Thromboembolism 16-3 16.1 Patient Safety Practice: Use of Aspirin for VTE Prophylaxis 16.1.1 Practice Description … for the prevention of VTE in patients undergoing major orthopedic surgery is located in the Practice Description … Author, Year Description of Patient Safety Practice Settings and Population Summary of Findings Implementation … Author, Year Description of Patient Safety Practice Study Design; Sample Size; Patient Population … for Introduction 16.1 Patient Safety Practice: Use of Aspirin for VTE Prophylaxis 16.1.1 Practice Description

711. Figure 2. Meta-analysis of the effect of screening and feedback on the proportion of patients with persistent depression, excluding the Katzelnick trial (12) | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/resources/depression/depsumfig2.html
     April 01, 2013 - reduction in persistent depression with screening as compared to no screening Select for Text Description

712. Relationship of Depression to Sickle Cell Disease Severity, Health Care Utilization and Quality of Life (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/decastro_grant.pdf
     September 01, 2013 - Institution/Partners: Duke University Project Period: 08/15/08-7/31/11 Grant Number: R21 HS17645-01 Description … Relationship of Depression to Sickle Cell Disease Severity, Health Care Utilization and Quality of Life Description

713. Optimizing Secondary Prevention in Type 2 Diabetes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/brown_grant.pdf
     September 01, 2013 - Foundation Research Institute Project Period: H2 07/21/08-12/20/09 Grant Number: R21 HS17643-01 Description … Updated 9/2013 Optimizing Secondary Prevention in Type 2 Diabetes Description Specific Aims Findings

714. Safety and Effectiveness Evaluations for Kidney Disease in Complex Patients (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/millerd_r21grant.pdf
     September 01, 2013 - Economic Research, Bedford VAMC Project Period: 09/30/10 – 09/29/12 Grant Number: R21 HS19526-01 Description … Updated 9/2013 Safety and Effectiveness Evaluations for Kidney Disease in Complex Patients Description

715. Outpatient Versus Residential Treatment Comparison for Pregnant Substance Abusers (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/mcfarland_r21grant.pdf
     September 01, 2013 - Health & Science University Project Period: 09/30/10 – 09/29/12 Grant Number: R21 HS19510-01 Description … Updated 9/2013 Outpatient Versus Residential Treatment Comparison for Pregnant Substance Abusers Description

716. Heart Risk Calculator | Agency for Healthcare Research and Quality
     www.ahrq.gov/evidencenow/heart-health/overall/risk.html
     August 01, 2018 - Heart Risk Calculator Resource title: Heart Risk Calculator Resource description:

717. 35. Intervention as a Covered Health Benefit (continued) | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-overview/slide35.html
     October 01, 2014 - Intervention as a Covered Health Benefit (continued) Treating Tobacco Use and DependencText description

718. Intro (pdf file)
     www.ahrq.gov/downloads/monahrq/pdf/MONAHRQ_v40_HostUserGuide.pdf
     August 01, 2012 - Measure and health topic description information d. … MONAHRQ software provides measure description information for describing the AHRQ QI. … Measure description information is stored in tables in the MONAHRQ database. … Each row contains the complete description of a single measure. … A description of the paths and pages generated can be found in Appendix G.

719. Figure B-2. General Process for Narrowing the Field of Measures | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/final-reports/pcpaccountability/pcpaccfigb2.html
     July 01, 2018 - Appendix C: Detailed Results of Measure Selection Process [ D ] Select for Text Description

720. Figure C-2. Narrowing the Field of Adult Primary Care Measures | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/final-reports/pcpaccountability/pcpaccfigc2.html
     July 01, 2018 - Appendix C: Detailed Results of Measure Selection Process [ D ] Select for Text Description